Scarica l'app Stockscreener
89.94
2.27%
2.00
Dopo l'orario di chiusura:
89.96
0.02
+0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.94
Aprire:
$87.64
Volume 24 ore:
10.05M
Relative Volume:
1.57
Capitalizzazione di mercato:
$115.42B
Reddito:
$33.20B
Utile/perdita netta:
$4.26B
Rapporto P/E:
27.34
EPS:
3.29
Flusso di cassa netto:
$5.47B
1 W Prestazione:
-3.09%
1M Prestazione:
+1.77%
6M Prestazione:
+2.74%
1 anno Prestazione:
+4.70%
Intervallo 1D:
$87.58
$91.15
Intervallo di 1 settimana:
$85.06
$91.15
Portata 52W:
$75.96
$93.08
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Is Medtronic Stock a Buy? - The Motley Fool
Medtronic’s Expansion Gains Momentum—Time for a Market Shift? - MarketBeat
$3.77 Bn Surgical Meshes Market Opportunities and - GlobeNewswire
U.S. Home Healthcare Market Booming with Increasing Adoption | Growth, Innovations & Share: 3M Healthcare, - EIN News
Dental Suture Market Detailed In New Research Report 2025 | Medtronic Plc., Sutumed Corp., Katsan Medical Devices - openPR
Medtronic launches spinal system for deformity procedures - Mass Device
Medtronic Offers Attractive Entry Point After Q3 Results, RBC Says -February 19, 2025 at 12:32 pm EST - Marketscreener.com
UBS raises Medtronic price target to $95, maintains Neutral rating By Investing.com - Investing.com UK
Stifel maintains Hold on Medtronic stock, price target at $87 - Investing.com India
Medtronic plc (NYSE:MDT) Q3 2025 Earnings Call Transcript - MSN
Cardiac Pacemaker Market Size, Trends & Growth Forecast 2024-2031 | Medtronic Plc., St. Jude Medical, Biotronik. - openPR
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and ... By GuruFocus - Investing.com Canada
Medtronic expects pressure in surgical unit for fourth quarter, shares fall - MSN
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and ... - Yahoo Finance
Medtronic stock holds as Raymond James maintains rating By Investing.com - Investing.com Nigeria
Medtronic Q3 Fiscal 2025 Financial Overview - TipRanks
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Hunting - MSN
Medtronic's diabetes device sales drive profit beat but surgical unit lags - MSN
Medtronic’s stock drops on inventory hiccup and revenue miss - MSN
MDT: 3 Healthcare IT Stocks Revolutionizing Patient Care - StockNews.com
Medtronic slightly misses on revenue in Q3 - Mass Device
Medtronic Earnings Review: Stuck In The Single Digits Again (NYSE:MDT) - Seeking Alpha
Why Medtronic Just Undercut Its Buy Zone With A 7% Drop - Yahoo
Medtronic slips after reaffirming full-year guidance - MSN
Medtronic Earnings: Softer Revenue Growth, but Tight Spending Control Supports Profits - Morningstar
Medtronic Misses Third-Quarter Revenue Views as Some Distributors Lower Inventory Levels - Marketscreener.com
Why Medtronic Just Undercut Its Buy Zone With A 5% Drop - MSN
Medtronic Sinks on Sales Miss – What Went Wrong? - Wall Street Pit
Medtronic nears FDA submission for Hugo robot - MedTech Dive
Top Midday Stories: Medtronic Shares Tumble on Revenue Miss; CNBC's Faber Reportedly Says Walgreens-Sycamore Deal Talks 'Now Alive' - Marketscreener.com
Medtronic's diabetes device sales drive profit beat but surgical unit lags -February 18, 2025 at 10:21 am EST - Marketscreener.com
Earnings call transcript: Medtronic Q3 2025 beats EPS estimates, stock dips - Investing.com
Medtronic's diabetes device sales drive profit beat but surgical unit lags By Reuters - Investing.com
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast - Benzinga
MDT Earnings: Medtronic Diabetes and Heart Devices Drive Beat - Markets Insider
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles - Yahoo Finance Australia
Medtronic's diabetes device sales drive profit beat but surgical unit lags -February 18, 2025 at 07:07 am EST - Marketscreener.com
Medtronic Q3 earnings beat estimates, revenue misses - MSN
Medtronic PLC Reports Q3 FY25 Earnings: GAAP EPS of $1.01 and Re - GuruFocus.com
Medtronic’s diabetes device sales drive profit beat but surgical unit lags - Blue Water Healthy Living
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit - AlphaStreet
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT) - StreetInsider.com
Medtronic plc Re-Iterates Earnings Guidance for the Full Year 2025 -February 18, 2025 at 06:47 am EST - Marketscreener.com
Medtronic: EPS up 7% in Q3 -February 18, 2025 at 07:48 am EST - Marketscreener.com
Medtronic stock slips after Q3 revenue miss (MDT:NYSE) - Seeking Alpha
Medtronic: Fiscal Q3 Earnings Snapshot - CTPost
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales - MSN
Medtronic earnings beat by $0.03, revenue fell short of estimates - Investing.com South Africa
Medtronic's Diabetes Device Sales Drive Profit Beat but Surgical Unit Lags - U.S News & World Report Money
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales -February 18, 2025 at 07:07 am EST - Marketscreener.com
Medtronic’s Third Quarter Fiscal 2025 Revenue Surges to $8.29B - The Tokenist
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):